NCT06152757 - BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 9, 2023

Primary Completion Date

July 19, 2025

Study Completion Date

July 19, 2027

Conditions

Gastrointestinal Tumors

Interventions

BIOLOGICAL

First dose

1.0×10\^8cells,Intravenous infusion，1 subject is planned to be enrolled

BIOLOGICAL

Second dose

3.0×10\^8cells,Intravenous infusion，3 subject is planned to be enrolled

BIOLOGICAL

The third dose

1.0×10\^9cells,Intravenous infusion，3 subject is planned to be enrolled

BIOLOGICAL

The fourth dose

3.0×10\^9cells,Intravenous infusion，3 subject is planned to be enrolled

Trial Locations (1)

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

lead

BioSyngen Pte Ltd

INDUSTRY